TWN Info Service on Intellectual Property Issues (2025)

BACK TO MAIN | ONLINE BOOKSTORE | HOW TO ORDER

TWN Info Service on Intellectual Property Issues (2025)

SELECT YEAR:

WTO: Talks on IP royalties blocked amid $98 billion paid by South for IP use
by D. Ravi Kanth (02 Dec 25)
UNGA draft resolution on rare diseases silent on IP barriers and TRIPS flexibilities
by K.M. Gopakumar (28 Nov 25)
Overlooked Potential Users of the PABS System and Implications for Benefit-Sharing
by Chetali Rao & Sangeeta Shashikant (28 Nov 25)
Indian regulator declines local Phase-III clinical trial waiver for Lenacapavir
by Chetali Rao & KM Gopakumar (13 Nov 25)
An Unequal and Incomplete PABS System: Legal Ambiguity and Key Omissions in Bureau's Draft Text
by Nithin Ramakrishnan & Sangeeta Shashikant (03 Nov 25)
EU's flawed PABS proposal is inconsistent with the Pandemic Agreement & masquerades corporate charity as benefit-sharing
by Nithin Ramakrishnan & Sangeeta Shashikant (29 Oct 25)
Indian Court rules against Roche and allows generic SMA drug
(10 Oct 25)
Health: Perilous Delay in Lenacapavir Registration Compromises Access in Developing Countries
by Chetali Rao (01 Oct 25)
Health: Draft UN Political Declaration on NCD silent on TRIPS flexibilities
by K M Gopakumar (31 Jul 25)
Trade: In new twist, WTO overturns panel ruling in EU-China IP dispute
by D. Ravi Kanth (23 Jul 25)
Health: Key HIV prevention drug could cost just $25 a year, finds study
by Kanaga Raja (18 Jul 25)
TWN statements at WIPO General Assemblies (8-17 July 2025)
(16 Jul 25)
Thailand: “Ever-greening” patents – the case of TB drug Bedaquiline
by Kanaga Raja (10 Jun 25)
Trade: US places eight countries, including China, on IP watch-list
by D. Ravi Kanth (06 May 25)
Civil Society and Farmers' Groups Urge Developing Country Parties to the Plant Treaty to Reject Inequitable Amendment Proposals
(22 Apr 25)
Health: Clinical efficacy studies proposed to be exception in EU biosimilar approvals
by Chetali Rao (10 Apr 25)
IP: Gilead amend Lenacapavir patent claims in attempt to save "patent evergreening" application
by Prathibha Sivasubramanian (02 Apr 25)
IP: Delhi High Court clears path for generic risdiplam availability in India
by Chetali Rao & K M Gopakumar (26 Mar 25)
IQVIA Report suggests US regulatory reform to fill "biosimilar void" (lessons for the South)
by Chetali Rao & K M Gopakumar (24 Mar 25)
Health: In significant move, Thailand rejects patent on vital Hepatitis C drug
by Kanaga Raja (28 Feb 25)
Health: In major win, a key HIV drug arrives in Colombia under a CL
by Kanaga Raja (21 Feb 25)
WHO: Cervical Cancer Resolution Overlooks Critical Treatment Disparities
by Chetali Rao & K M Gopakumar (04 Feb 25)
WHO: Rare Disease Resolution Is Silent On Use Of TRIPS Flexibilities
by Chetali Rao & K M Gopakumar (03 Feb 25)

BACK TO MAIN | ONLINE BOOKSTORE | HOW TO ORDER